Dr. Huang brings over 25 years of biopharmaceutical development experience, specializing in CMC development and regulatory submissions for investigational biologics from Phase I through Phase III. His expertise spans analytical development, characterization, formulation, quality control, and drug substance and drug product release.

At Sound Biologics, Dr. Huang leads the Biopharmaceutical Sciences team, oversees CDMO activities, and is responsible for CMC regulatory document preparation and FDA submissions. Before joining Sound Biologics in 2017, he held scientific and leadership positions at Human Genome Sciences, ICOS/CMC Biologics, Amgen, and Bristol Myers Squibb.

Dr. Huang earned his Ph.D. from the Chinese Academy of Sciences and completed a postdoctoral fellowship in biochemical engineering at Yale University.